extra[not]ordinary® な未来を共に築くことを使命とし、革新的な抗体製品の開発や人々を感動させる抗体医薬品で、がんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え、治療の未来を切り拓いています。
Overview
The Sr. Manager, Japan Clinical Trial Manager (JCTM) is accountable for delivery of Japan and / or selected deliverables within a trial (e.g., manage and oversee vendor deliverables, collaborate with functions to set up activities [e.g., eCRF, IRT, eRT], support site activation and recruitment, support data review / cleaning activities, support PI / ICF development). Scope of responsibilities depending on number of patients / sites / size of trial.
The Sr. Manager, JCTM is accountable for the end-to-end delivery of a single clinical trial from strategy outline through to CSR by leading cross-functional trial specific Clinical Trial Team (CTT) to deliver clinical trials including managing the trial budget if assigned to a trial as Global Clinical Trial Manager (GCTM).
As Sr. Manager, JCTM, the employee represents Japan Development Operations (JDO) in one or more Japan Compound Teams (J-CoT) and contributes to the compound development strategy in Japan.
Responsibilities / tasks as CTM
Trial Planning and Oversight
- Set target timeline, target number of patients, and required number of sites in Japan together with GCTM, JCoT members, CRO, and other related stakeholders
- Review Task Orders with CROs for Japan
- Involve in optimizing site costs in Japan as needed
- Develop operational plans, manuals and charters for the trial
- Review protocol and protocol amendments
- Coordinate development of Trial Oversight Plan
- Review Investigator's Brochure (IB) from DevOps perspective
- Review Clinical Trial Application (CTA) submission package
- Review Regulatory Green Light (RGL) packages in accordance with QDOC-
- Review Development Safety Update Report (DSUR)
- Develop Global Master ICF
- Follow up on Trial Oversight identified findings during Oversight until closure
Site Selection and Management
Drive site selection in collaboration with Start-upReview and approve selected sites in JapanReview / approve SSV summaryCoordinate review of CRO country-specific informed consent forms (ICFs) with internalstakeholders
Coordinate translation / back translation process of ICFsVendor Management and Oversight
Oversee vendor management across vendors (does not include budget / change orders)Approve key CRO staff e.g., Clinical leads, or Trial specific CRA (not including CRAs partof the partnership dedicated model which is managed via Oversight Manager)
Trial Execution and Monitoring
Ensure achievement of key milestones (CTN submission, FPI, LPI, etc.) in JapanConduct initial Protocol Deviation (PD) assessments and track trendsEnsure the ongoing completeness of the electronic Trial Master File (eTMF)Keep the Trial Management Dashboard (TMD) and portfolio app in GenSense up to dateDrive the ODB review meetingParticipate in RBQM activities (as implemented going forward)Assist in maintenance of CTT issue log in collaboration with GCTMCollaborate or manage study escalations both internal & externalSupport GCTM to Assess KPI / KQI at the trial levelSupport QA in site audit activities and potentially vendor audits (supporting with trialinformation and collection and providing of relevant trial documents)
Conduct booster visitsParticipate in inspection readiness activities as assignedOversee and collaborate with CTT members / vendors / assigned functional representativeson tracking and reconciliation of trial related items such as scans, blood samples etc.
Responsibilities / tasks as GCTM
Trial Leadership and Management :
Lead the Clinical Trial Team (CTT)Lead the Trial Management (TM) teamDefine and manage CTT goals (together with CTT)Review and approve protocol and amendment changesReview Master ICFApprove operational plans, manuals and charters for the trialOversee vendor selection processInitiate and ensure the accuracy and completeness of initial Work Order (WO) / Change Orders (CO)Drive country selection processCoordinate and respond to IEC / IRB commentsOverview of major PDs and PD trendingApprove data cleaning plansWork closely with CPL as needed for CST / CDTEnsure responsibility split is developed and maintainedReview and contribute to CSR as neededEscalate issues to CPL in a timely mannerExecute operational strategy related to Drug supplyExecute regulatory submission strategyExecute recruitment strategyBudget and Planning :
Assist in initial development and Manage trial budgetPlan, implement & ensure maintenance detailed integrated trial timelines from studyoutline though CSR (Gap : GCTM / CPL need a planner, e.g., MS Project, to show end to
end project timelines and to build trust in organization)
Develop initial recruitment projections and strategyApprove re-baseline recruitment projections in alignment with CPLAct as counterpart for CRO PL / PM and approve CV of PL / PMRisk management :
Conduct study risks identification with CTT & risks management activitiesOversee CTT issue log and issue resolutionOversee CTT Action / Decision logs are maintainedAssist in preparation for & responses to auditsEnsure CAPAs are in place, if applicableJapan specific responsibilities / tasks
Drug Development in Japan :
Represent JDO in one or more J-CoTo Work with JCTM to ensure each study progress and milestone achievement in
Japan
o Ensure that departmental input / knowledge that could impact the setup and
conduct of trials is proactively considered and discussed upon operationalization of the trials
o Proactively provide input on the development strategy of compound as a
representative of JDO
Participate in preparation for and response to PMDA Inspection as a representative of JDOProactively join a cross functional activity including a process development / improvementCollaborate with critical external stakeholders (e.g. CROs, vendors, experts) to drive long-term objectives across projects / programs, if applicableParticipate in external initiatives / task force teams such as EFPIA and JPMA and bring experience and knowledge to the relevant stakeholders, if applicableMentor other colleaguesThe Employee shall also render such other related services and duties as may be assigned from time to time by supervisor.
LI-DNP
25年間、情熱的で革新的、そして協力的なチームが、次世代抗体技術プラットフォームを開発し、トランスレーショナルサイエンス、定量科学、データサイエンスを活用することで、独自のパイプラインを確立してきました。このパイプラインには、二重特異性T細胞エンゲージャー(bispecific T-cell engagers)、抗体薬物複合体(ADC)、次世代免疫チェックポイントモジュレーター、エフェクター機能強化抗体などが含まれています。
Job Applicant Privacy Notice )